Sign inJoin waitlistJoin the waitlist

Christopher Rangel

Assistant Professor, Hematology & Oncology · Medical University of South Carolina College of Medicine

Credentials: · · · ·

History

Medical University of South Carolina College of Medicine
Present

Medical Oncology
2018–2020
Internal Medicine
Medical University of South Carolina College of Medicine
2016–2018
Virginia Commonwealth University School of Medicine
2012–2016

Research

Rechallenge of an alternative CDK 4/6 inhibitor after hepatotoxicity in the treatment of hormone-positive metastatic breast cancer
Case report · Journal of Oncology Pharmacy Practice · 2025 · 3 citations

Frank Brescia
1 paper

Clinical trials

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2, Phase 3
SWOG Cancer Research Network
2025–2028
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2032
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2039
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2023–2028